Infinity Pharmaceuticals (INFI)

Add to Watchlists
Create an Alert
8.83 -0.45  -4.85% NASDAQ Aug 31, 17:00 Delayed 2m USD
View Full Chart
INFI Price Chart
View All Events

INFI Events

Date Type Description
08/06/2015 08:30 EDT Misc Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2015
08/06/2015 Earnings Infinity Pharmaceuticals Inc Second Quarter Earnings in 2015 Release
05/06/2015 08:30 EST Misc Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call in 2015
05/06/2015 Earnings Infinity Pharmaceuticals Inc First Quarter Earnings in 2015 Release
02/24/2015 16:30 EST Misc Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2014
02/24/2015 Earnings Infinity Pharmaceuticals Inc Fourth Quarter Earnings in 2014 Release
01/12/2015 14:30 EST Misc Infinity to Present at J.P. Morgan 33rd Annual Healthcare Conference
11/06/2014 16:30 EDT Misc Q3 2014 Infinity Pharmaceuticals, Inc. Earnings Conference Call
11/06/2014 Earnings Q3 2014 Infinity Pharmaceuticals, Inc. Earnings Result
View All Performance Charts

INFI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Infinity Pharmaceuticals is down 21.02% over the last year vs S&P 500 Total Return up 0.82%, AVEO Pharmaceuticals up 6.98%, and Corcept Therapeutics up 80.51%.

Advertisement

INFI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.infi.com
  • IR Website: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: June 30, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its primary product candidate is duvelisib, also known as IPI-145, an oral inhibitor.

INFI Excel Add-In Codes

  • Name: =YCI("INFI","name")
  • Description: =YCI("INFI","description")
  • Sector: =YCI("INFI","sector")
  • Industry: =YCI("INFI","industry")
  • Est. Current Fiscal Year End: =YCI("INFI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.